Joseph Hatef, DPM
Foot & Ankle Surgery · Corning, NYNPI 1730184185
Payments from drug & device makers
What this record shows
This record is dominated by other: $52,800 of the $53,076 with a category attached, or 99.5%. Convatec Inc. accounts for 99.8% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $52,949, more than ten times the $15 reported in 2019. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 19 payments — averaging $2793.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$53K
- Organogenesis Inc.$40
- Acumed LLC$34
- Orthofix Medical, Inc.$15
What the payments were for
- Food & beverage$2761%
- Other$52,80099%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 16 | $52,986 |
| Organogenesis Inc. | 1 | $40 |
| Acumed LLC | 1 | $34 |
| Orthofix Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$52,800
How this compares
$53,076 in reported general payments places this provider in the 95th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 145 | $1,993 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $677 |
| Clindamycin Hcl | 51 | $435 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $132 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $56 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Corning
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4M
- George Vitole Roy$2.5M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Michael KellerKingston$532K
- Judith BaumhauerRochester$328K
- Stuart MogulNew York$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.